M L Plunkett
- Immunology top 5%
- Molecular Biology
- Immunology and Allergy top 2%
- Radiology, Nuclear Medicine and Imaging top 5%
- Oncology
- Co-authors
- Timothy A. SpringerMichael L. DustinMartin E. SandersPeriasamy SelvarajStephen ShawAndrew P. MazarFernando DoñateDavid E. Shaw
- Topics
- Angiogenesis and VEGF in Cancer (5 papers)Monoclonal and Polyclonal Antibodies Research (5 papers)Cell Adhesion Molecules Research (4 papers)
- Partner nations
- United StatesCanadaSpain
In The Last Decade
M L Plunkett
20 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 99
- Immunology 602
- Molecular Biology 518
- Immunology and Allergy 333
- Radiology, Nuclear Medicine and Imaging 293
- Oncology 208
Countries citing papers authored by M L Plunkett
This map shows the geographic impact of M L Plunkett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M L Plunkett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M L Plunkett more than expected).
Fields of papers citing papers by M L Plunkett
This network shows the impact of papers produced by M L Plunkett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M L Plunkett. The network helps show where M L Plunkett may publish in the future.
Co-authorship network of co-authors of M L Plunkett
This figure shows the co-authorship network connecting the top 25 collaborators of M L Plunkett. A scholar is included among the top collaborators of M L Plunkett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M L Plunkett. M L Plunkett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 77 | |
| 2 | 109 | |
| 3 | 165 | |
| 4 | Regression of primary breast tumor and blockage of osteolytic skeletal metastasis by a non-RGD based integrin binding peptide (ATN-161) targeting α5β1 and αvβ3 in a xenograft model of breast cancer | 1 |
| 5 | 47 | |
| 6 | 15 | |
| 7 | Histidine-proline-rich glycoprotein has potent antiangiogenic activity mediated through the histidine-proline-rich domain. | 81 |
| 8 | 5 | |
| 9 | 114 | |
| 10 | A quantitative in vivo mouse model used to assay inhibitors of tumor-induced angiogenesis. | 22 |
| 11 | An in vivo quantitative angiogenesis model using tumor cells entrapped in alginate. | 58 |
| 12 | THE LYMPHOCYTE-T GLYCOPROTEIN CD2 (LFA-2/T11/E-ROSETTE RECEPTOR) BINDS THE CELL-SURFACE LIGAND LFA-3 | 11 |
| 13 | 117 | |
| 14 | 398 | |
| 15 | 38 | |
| 16 | 31 | |
| 17 | 26 | |
| 18 | 5 | |
| 19 | 6 | |
| 20 | 8 |
About M L Plunkett
M L Plunkett is a scholar working on Immunology and Allergy, Hematology and Cancer Research, having authored 20 papers that have together received 1.3k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Cell Adhesion Molecules Research (4 papers). The work is most often cited by research in Immunology and Allergy (333 citations), Immunology (602 citations) and Radiology, Nuclear Medicine and Imaging (293 citations). M L Plunkett has collaborated with scholars based in United States, Canada and Spain. Frequent co-authors include Timothy A. Springer, Michael L. Dustin, Martin E. Sanders, Periasamy Selvaraj, Stephen Shaw, Andrew P. Mazar, Fernando Doñate, David E. Shaw, Graham C. Parry and Terry Riss. Their work appears in journals such as Nature, The Journal of Experimental Medicine and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.